Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

REGolution A training program on novel quantitative methods in regulatory decision making

Coordinator
Universiteit Utrecht, Netherlands
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.3m
Total cost
—
Partners
16 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101312586

What the project is doing

In the project's own words, from its summary on CORDIS.

REGolution aims to train doctoral candidates in advancing cutting-edge quantitative methodologies that align robust regulatory decision-making with the rapid scientific and technological developments transforming modern drug development. The project will generate innovative frameworks that strengthen the scientific basis of benefit–risk assessment, integrate real-world data (RWD) and advanced analytics, and accelerate the responsible adoption of novel approaches in regulatory science to the benefit of patients.

Fourteen doctoral candidates will form a multidisciplinary network to advance methodological innovations for clinical trials, improve the use and analysis of RWD for underrepresented populations, develop and evaluate methods to improve regulatory and Health Technology Assessment decision-making, and create AI-driven, transparent research methodologies across the medicine lifecycle. Together, they will produce open-access, novel methodological frameworks and software, case studies, and guidance-oriented insights to support more reliable, interpretable, and efficient evidence for regulatory use.

Results will be disseminated broadly to regulators, the scientific community, and patient stakeholders to maximise impact, whereas the doctoral candidates will acquire technical and transferable skills that provide a firm base for diverse careers. The project aligns closely with the MSCA Work Programme by educating young researchers through training, interdisciplinary and intersectoral mobility, strong academic–regulatory collaboration, and high societal relevance.

The doctoral candidates will obtain advanced methodological, regulatory and transferable expertise, enhancing employability within and beyond academia and enabling conversion of innovative ideas into tools, frameworks and services relevant to regulatory and pharmacoepidemiological practice. The structure of the REGolution project will ensure strong communication, collaboration, and dissemination skills.

Topics

Who is involved

OrganisationCityCountryRole
Universiteit UtrechtUtrechtNetherlandsCoordinator
Bundesinstitut Fur Impfstoffe Und Biomedizinische ArzneimittelLangenGermanyParticipant
Friedrich-Alexander-Universitaet Erlangen-NuernbergErlangenGermanyAssociatedpartner
Gottfried Wilhelm Leibniz Universitaet HannoverHannoverGermanyParticipant
Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen RechtsGoettingenGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
LaegemiddelstyrelsenKobenhavn SDenmarkAssociatedpartner
Panepistimio IoanninonIoanninaGreeceParticipant
Agence Nationale De Securite Du Medicament Et Des Produits De SanteSaint Denis CedexFranceAssociatedpartner
Universite Paris CiteParisFranceParticipant
Agentschap College Ter Beoordeling Van GeneesmiddelenUtrechtNetherlandsAssociatedpartner
Stichting Radboud Universitair Medisch CentrumNijmegenNetherlandsParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsAssociatedpartner
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Direktoratet for Medisinske ProdukterOsloNorwayAssociatedpartner
Universitetet I OsloOsloNorwayParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI